Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons

Angela R. Evans, Grant Nicol, Michael Vasko

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

To determine whether the sensitizing actions of prostaglandins on sensory neurons are due to modulation of voltage-sensitive calcium channels (VSCC) we examined the effects of inhibiting these channels on PGE2-induced enhancement of evoked peptide release from isolated dorsal root ganglion neurons. The inhibitory effects of the VSCC blockers on stimulated release were dependent upon the type of chemical agent used to evoke the release. Bradykinin-stimulated release of immunoreactive substance P (iSP) and calcitonin gene-related peptide (iCGRP) was attenuated by the N-type VSCC blocker, ω-conotoxin GVIA (100 nM), but was unaffected by blockade of L-type (1 μM nifedipine) or P-type (200 nM ω-agatoxin IVA) VSCC. In contrast, potassium-stimulated release of peptides was inhibited by nifedipine, but not by ω-conotoxin GVIA or ω-agatoxin IVA. None of the VSCC blockers tested attenuated capsaicin-stimulated release of iSP and iCGRP. The combination of 1 μM nifedipine and 100 nM ω-conotoxin GVIA reduced the whole cell calcium current 89% ± 1.7%. Administration of 100 nM PGE2 potentiated bradykinin- and capsaicin-evoked peptide release by 2-3-fold. Neither nifedipine nor ω-conotoxin GVIA attenuated the PGE2-mediated potentiation of bradykinin-evoked release, and neither ω-conotoxin GVIA nor ω-agatoxin IVA blocked the potentiation of capsaicin-evoked release induced by PGE2. These results indicate that the sensitizing actions of PGE2 as measured by enhanced peptide release, are not mediated by L-, N-, or P-type VSCC.

Original languageEnglish
Pages (from-to)265-273
Number of pages9
JournalBrain Research
Volume712
Issue number2
DOIs
StatePublished - Mar 18 1996

Fingerprint

Conotoxins
Sensory Receptor Cells
Calcium Channels
Agatoxins
Dinoprostone
Nifedipine
Capsaicin
Calcium Channel Blockers
Bradykinin
Peptides
Calcitonin Gene-Related Peptide
Substance P
Spinal Ganglia
Prostaglandins
Potassium
Calcium
Neurons

Keywords

  • ω-agatoxin
  • ω-conotoxin
  • bradykinin
  • capsaicin
  • nifedipine
  • prostaglandin
  • release
  • voltage-sensitive calcium channel

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons. / Evans, Angela R.; Nicol, Grant; Vasko, Michael.

In: Brain Research, Vol. 712, No. 2, 18.03.1996, p. 265-273.

Research output: Contribution to journalArticle

@article{7febfeaccb9e40a2a64e4d62e526a4c0,
title = "Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons",
abstract = "To determine whether the sensitizing actions of prostaglandins on sensory neurons are due to modulation of voltage-sensitive calcium channels (VSCC) we examined the effects of inhibiting these channels on PGE2-induced enhancement of evoked peptide release from isolated dorsal root ganglion neurons. The inhibitory effects of the VSCC blockers on stimulated release were dependent upon the type of chemical agent used to evoke the release. Bradykinin-stimulated release of immunoreactive substance P (iSP) and calcitonin gene-related peptide (iCGRP) was attenuated by the N-type VSCC blocker, ω-conotoxin GVIA (100 nM), but was unaffected by blockade of L-type (1 μM nifedipine) or P-type (200 nM ω-agatoxin IVA) VSCC. In contrast, potassium-stimulated release of peptides was inhibited by nifedipine, but not by ω-conotoxin GVIA or ω-agatoxin IVA. None of the VSCC blockers tested attenuated capsaicin-stimulated release of iSP and iCGRP. The combination of 1 μM nifedipine and 100 nM ω-conotoxin GVIA reduced the whole cell calcium current 89{\%} ± 1.7{\%}. Administration of 100 nM PGE2 potentiated bradykinin- and capsaicin-evoked peptide release by 2-3-fold. Neither nifedipine nor ω-conotoxin GVIA attenuated the PGE2-mediated potentiation of bradykinin-evoked release, and neither ω-conotoxin GVIA nor ω-agatoxin IVA blocked the potentiation of capsaicin-evoked release induced by PGE2. These results indicate that the sensitizing actions of PGE2 as measured by enhanced peptide release, are not mediated by L-, N-, or P-type VSCC.",
keywords = "ω-agatoxin, ω-conotoxin, bradykinin, capsaicin, nifedipine, prostaglandin, release, voltage-sensitive calcium channel",
author = "Evans, {Angela R.} and Grant Nicol and Michael Vasko",
year = "1996",
month = "3",
day = "18",
doi = "10.1016/0006-8993(95)01447-0",
language = "English",
volume = "712",
pages = "265--273",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons

AU - Evans, Angela R.

AU - Nicol, Grant

AU - Vasko, Michael

PY - 1996/3/18

Y1 - 1996/3/18

N2 - To determine whether the sensitizing actions of prostaglandins on sensory neurons are due to modulation of voltage-sensitive calcium channels (VSCC) we examined the effects of inhibiting these channels on PGE2-induced enhancement of evoked peptide release from isolated dorsal root ganglion neurons. The inhibitory effects of the VSCC blockers on stimulated release were dependent upon the type of chemical agent used to evoke the release. Bradykinin-stimulated release of immunoreactive substance P (iSP) and calcitonin gene-related peptide (iCGRP) was attenuated by the N-type VSCC blocker, ω-conotoxin GVIA (100 nM), but was unaffected by blockade of L-type (1 μM nifedipine) or P-type (200 nM ω-agatoxin IVA) VSCC. In contrast, potassium-stimulated release of peptides was inhibited by nifedipine, but not by ω-conotoxin GVIA or ω-agatoxin IVA. None of the VSCC blockers tested attenuated capsaicin-stimulated release of iSP and iCGRP. The combination of 1 μM nifedipine and 100 nM ω-conotoxin GVIA reduced the whole cell calcium current 89% ± 1.7%. Administration of 100 nM PGE2 potentiated bradykinin- and capsaicin-evoked peptide release by 2-3-fold. Neither nifedipine nor ω-conotoxin GVIA attenuated the PGE2-mediated potentiation of bradykinin-evoked release, and neither ω-conotoxin GVIA nor ω-agatoxin IVA blocked the potentiation of capsaicin-evoked release induced by PGE2. These results indicate that the sensitizing actions of PGE2 as measured by enhanced peptide release, are not mediated by L-, N-, or P-type VSCC.

AB - To determine whether the sensitizing actions of prostaglandins on sensory neurons are due to modulation of voltage-sensitive calcium channels (VSCC) we examined the effects of inhibiting these channels on PGE2-induced enhancement of evoked peptide release from isolated dorsal root ganglion neurons. The inhibitory effects of the VSCC blockers on stimulated release were dependent upon the type of chemical agent used to evoke the release. Bradykinin-stimulated release of immunoreactive substance P (iSP) and calcitonin gene-related peptide (iCGRP) was attenuated by the N-type VSCC blocker, ω-conotoxin GVIA (100 nM), but was unaffected by blockade of L-type (1 μM nifedipine) or P-type (200 nM ω-agatoxin IVA) VSCC. In contrast, potassium-stimulated release of peptides was inhibited by nifedipine, but not by ω-conotoxin GVIA or ω-agatoxin IVA. None of the VSCC blockers tested attenuated capsaicin-stimulated release of iSP and iCGRP. The combination of 1 μM nifedipine and 100 nM ω-conotoxin GVIA reduced the whole cell calcium current 89% ± 1.7%. Administration of 100 nM PGE2 potentiated bradykinin- and capsaicin-evoked peptide release by 2-3-fold. Neither nifedipine nor ω-conotoxin GVIA attenuated the PGE2-mediated potentiation of bradykinin-evoked release, and neither ω-conotoxin GVIA nor ω-agatoxin IVA blocked the potentiation of capsaicin-evoked release induced by PGE2. These results indicate that the sensitizing actions of PGE2 as measured by enhanced peptide release, are not mediated by L-, N-, or P-type VSCC.

KW - ω-agatoxin

KW - ω-conotoxin

KW - bradykinin

KW - capsaicin

KW - nifedipine

KW - prostaglandin

KW - release

KW - voltage-sensitive calcium channel

UR - http://www.scopus.com/inward/record.url?scp=0029865382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029865382&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(95)01447-0

DO - 10.1016/0006-8993(95)01447-0

M3 - Article

C2 - 8814901

AN - SCOPUS:0029865382

VL - 712

SP - 265

EP - 273

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -